In two mouse models of cachexia, tumor derived IL-6 led to the reprogramming of hepatic metabolism via suppression of peroxisome proliferator-activated receptor alpha (PPARα) regulated ketogenesis that subsequently induced increased endogenous glucocorticoid secretion, which in turn impaired antitumor immunity and resistance to immunotherapy [49]. This evidence concerns the gene IL6 and Cachexia.